Logo image of AWH

ASPIRA WOMEN'S HEALTH INC (AWH) Stock Fundamental Analysis

NASDAQ:AWH - Nasdaq - US04537Y2081 - Common Stock - Currency: USD

0.082  -0.01 (-12.49%)

After market: 0.0395 -0.04 (-51.83%)

Fundamental Rating

2

Taking everything into account, AWH scores 2 out of 10 in our fundamental rating. AWH was compared to 189 industry peers in the Health Care Equipment & Supplies industry. AWH has a bad profitability rating. Also its financial health evaluation is rather negative. AWH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AWH had negative earnings in the past year.
AWH had a negative operating cash flow in the past year.
In the past 5 years AWH always reported negative net income.
AWH had a negative operating cash flow in each of the past 5 years.
AWH Yearly Net Income VS EBIT VS OCF VS FCFAWH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

AWH's Return On Assets of -238.46% is on the low side compared to the rest of the industry. AWH is outperformed by 94.24% of its industry peers.
Industry RankSector Rank
ROA -238.46%
ROE N/A
ROIC N/A
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AWH Yearly ROA, ROE, ROICAWH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

AWH's Gross Margin of 59.67% is in line compared to the rest of the industry. AWH outperforms 58.64% of its industry peers.
In the last couple of years the Gross Margin of AWH has grown nicely.
The Profit Margin and Operating Margin are not available for AWH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
AWH Yearly Profit, Operating, Gross MarginsAWH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

AWH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AWH has been increased compared to 1 year ago.
AWH has more shares outstanding than it did 5 years ago.
AWH has a worse debt/assets ratio than last year.
AWH Yearly Shares OutstandingAWH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
AWH Yearly Total Debt VS Total AssetsAWH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

AWH has an Altman-Z score of -143.66. This is a bad value and indicates that AWH is not financially healthy and even has some risk of bankruptcy.
AWH has a Altman-Z score of -143.66. This is amonst the worse of the industry: AWH underperforms 96.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -143.66
ROIC/WACCN/A
WACC7.54%
AWH Yearly LT Debt VS Equity VS FCFAWH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.76 indicates that AWH may have some problems paying its short term obligations.
The Current ratio of AWH (0.76) is worse than 91.62% of its industry peers.
AWH has a Quick Ratio of 0.76. This is a bad value and indicates that AWH is not financially healthy enough and could expect problems in meeting its short term obligations.
AWH has a Quick ratio of 0.71. This is amonst the worse of the industry: AWH underperforms 87.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.71
AWH Yearly Current Assets VS Current LiabilitesAWH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.50% over the past year.
AWH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.24%.
The Revenue has been growing by 15.13% on average over the past years. This is quite good.
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%

3.2 Future

AWH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.55% yearly.
Based on estimates for the next years, AWH will show a very strong growth in Revenue. The Revenue will grow by 64.54% on average per year.
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AWH Yearly Revenue VS EstimatesAWH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M
AWH Yearly EPS VS EstimatesAWH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AWH. In the last year negative earnings were reported.
Also next year AWH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AWH Price Earnings VS Forward Price EarningsAWH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AWH Per share dataAWH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as AWH's earnings are expected to grow with 32.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.55%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AWH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASPIRA WOMEN'S HEALTH INC

NASDAQ:AWH (4/16/2025, 8:00:01 PM)

After market: 0.0395 -0.04 (-51.83%)

0.082

-0.01 (-12.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)05-13 2025-05-13/bmo
Inst Owners10.64%
Inst Owner Change0%
Ins Owners13.72%
Ins Owner Change1.02%
Market Cap2.89M
Analysts80
Price Target5.61 (6741.46%)
Short Float %0.47%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.81%
Min Revenue beat(2)-19.22%
Max Revenue beat(2)-18.41%
Revenue beat(4)0
Avg Revenue beat(4)-15.56%
Min Revenue beat(4)-19.22%
Max Revenue beat(4)-7.73%
Revenue beat(8)0
Avg Revenue beat(8)-15.76%
Revenue beat(12)0
Avg Revenue beat(12)-13.9%
Revenue beat(16)3
Avg Revenue beat(16)-9.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.26
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -238.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.67%
FCFM N/A
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
F-Score4
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.22%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.71
Altman-Z -143.66
F-Score4
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)46.91%
Cap/Depr(5y)76.44%
Cap/Sales(3y)1.16%
Cap/Sales(5y)3.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%
EBIT growth 1Y13.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.79%
OCF growth 3YN/A
OCF growth 5YN/A